A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/675 (2006.01) A61K 31/66 (2006.01) C07F 9/58 (2006.01) C07F 9/59 (2006.01)
Patent
CA 2138367
The use of a high potency phosphonate for increasing bone mass in a human or other mammal subject afflicted with osteoporosis, wherein the high potency phosphonate is used in a thirty day program in an amount of from 0.00001 mg P/kg to 0.1 mg P/kg of the subject per day for at least one day of the thirty day program, followed if required by a rest period of at least one day at the end of the thiry day program.
Utilisation d'un phosphonate à grande puissance pour l'accroissement de la masse osseuse chez les humains ou chez d'autres mammifères souffrant d'ostéoporose, dans le cadre d'un programme d'administration de trente jours à raison de 0,00001 à 0,1 mg P/kg de masse corporelle du sujet par jour pendant au moins un des trente jours du programme, avec au besoin une période de repos d'au moins un jour à la fin du programme de trente jours.
Boyce Rogely Waite
Francis Marion David
Kirby Eades Gale Baker
Procter & Gamble Pharmaceuticals Inc.
LandOfFree
Use of phosphonates for the treatment of osteoporosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of phosphonates for the treatment of osteoporosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of phosphonates for the treatment of osteoporosis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1936248